Cargando…

Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy

BACKGROUND: The use of immune checkpoint inhibitors (ICI) is associated with cardiovascular (CV) events, and patients with pre-existing autoimmune disease are at increased CV risk. OBJECTIVES: The aim of this study was to characterize the risk for CV events in patients with pre-existing autoimmune d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Charlotte, Drobni, Zsofia D., Zafar, Amna, Gongora, Carlos A., Zlotoff, Daniel A., Alvi, Raza M., Taron, Jana, Rambarat, Paula K., Schoenfeld, Sara, Mosarla, Ramya C., Raghu, Vineet K., Hartmann, Sarah E., Gilman, Hannah K., Murphy, Sean P., Sullivan, Ryan J., Faje, Alexander, Hoffmann, Udo, Zhang, Lili, Mayrhofer, Thomas, Reynolds, Kerry L., Neilan, Tomas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830202/ https://www.ncbi.nlm.nih.gov/pubmed/36636443 http://dx.doi.org/10.1016/j.jaccao.2022.11.008

Ejemplares similares

Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors
por: Drobni, Zsofia D, et al.
Publicado: (2021)

Pericardial disease in patients treated with immune checkpoint inhibitors
por: Gong, Jingyi, et al.
Publicado: (2021)

The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil–Associated Coronary Vasospasm
por: Zafar, Amna, et al.
Publicado: (2021)

Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis
por: Drobni, Zsofia D., et al.
Publicado: (2020)

The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm
por: Zafar, Amna, et al.
Publicado: (2022)

Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors
por: Drobni, Zsofia D., et al.
Publicado: (2022)

Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer
por: Drobni, Zsofia Dora, et al.
Publicado: (2023)

COMMON NONCARDIOVASCULAR MULTIMORBIDITY PATTERNS AND OUTCOMES IN OLDER ADULTS WITH MAJOR CARDIOVASCULAR DISEASE
por: Sison, Stephanie Denise, et al.
Publicado: (2022)

Neuropsychiatric consequences of coronary artery bypass grafting and noncardiovascular surgery
por: Reichenberg, Abraham, et al.
Publicado: (2007)

Early noncardiovascular organ failure and mortality in the cardiac intensive care unit
por: Jentzer, Jacob C., et al.
Publicado: (2020)

EFFECT OF TOCILIZUMAB ON CARDIAC INJURY AND DYSFUNCTION IN COVID-19
por: Zafar, Amna, et al.
Publicado: (2021)

Association Between Life's Simple 7 and Noncardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis
por: Ogunmoroti, Oluseye, et al.
Publicado: (2016)

Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons
por: Sahlberg, Marie, et al.
Publicado: (2015)

Derivation of Patient-Defined Adverse Cardiovascular and Noncardiovascular Events Through a Modified Delphi Process
por: Sun, Louise Y., et al.
Publicado: (2021)

Long‐term incidence and risk of noncardiovascular and all‐cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy
por: Fox, Philip R., et al.
Publicado: (2019)

The Prediction of Cardiac Events Using Contemporary Risk Prediction Models after Radiation Therapy for Head and Neck Cancer
por: Alvi, Raza M., et al.
Publicado: (2022)

Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long‐Term Follow‐Up After Acute Coronary Syndromes
por: Fanaroff, Alexander C., et al.
Publicado: (2017)

Association of Undifferentiated Dyspnea in Late Life With Cardiovascular and Noncardiovascular Dysfunction: A Cross-sectional Analysis From the ARIC Study
por: Ramalho, Sergio H. R., et al.
Publicado: (2019)

Aortic Stiffness: Epidemiology, Risk Factors, and Relevant Biomarkers
por: Angoff, Rebecca, et al.
Publicado: (2021)

Genetically Predicted Differences in Systolic Blood Pressure and Risk of Cardiovascular and Noncardiovascular Diseases: A Mendelian Randomization Study in Chinese Adults
por: Clarke, Robert, et al.
Publicado: (2023)

Association of fine particulate matter exposure with acute noncardiovascular critical illnesses and in-hospital outcomes in patients receiving intensive cardiac care
por: Chen, Fei, et al.
Publicado: (2020)

High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis
por: Duprez, Daniel A, et al.
Publicado: (2015)

SOLUBLE P-SELECTIN, PLATELET ACTIVITY AND RISK OF MORBIDITY AND MORTALITY IN COVID-19
por: Mosarla, Ramya, et al.
Publicado: (2022)

Guideline-Based Statin Eligibility, Coronary Artery Stenosis and Cardiovascular Events in Patients with Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial
por: Pursnani, Amit, et al.
Publicado: (2020)

Radiologists can visually predict mortality risk based on the gestalt of chest radiographs comparable to a deep learning network
por: Weiss, Jakob, et al.
Publicado: (2021)

Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
por: Zubiri, Leyre, et al.
Publicado: (2021)

Frailty as a Risk Factor for Cardiovascular Versus Noncardiovascular Mortality in Older Men: Results From the MrOS Sleep (Outcomes of Sleep Disorders in Older Men) Study
por: Adabag, Selcuk, et al.
Publicado: (2018)

Hypophysitis: Evaluation and Management
por: Faje, Alexander
Publicado: (2016)

Chronic lymphocytic leukemia, a rare cause of pituitary stalk thickening
por: Faje, Alexander
Publicado: (2020)

Electrocardiographic features of immune checkpoint inhibitor associated myocarditis
por: Zlotoff, Daniel A, et al.
Publicado: (2021)

State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet?
por: Mosarla, Ramya C., et al.
Publicado: (2022)

2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards
por: Bozkurt, Biykem, et al.
Publicado: (2022)

Immune‐Related Adverse Events in the Setting of PD‐1/L1 Inhibitor Combination Therapy
por: Zubiri, Leyre, et al.
Publicado: (2019)

A strategy utilizing ambulatory monitoring and home and clinic blood pressure measurements to optimize the safety evaluation of noncardiovascular drugs with potential for hemodynamic effects: a report from the SYNERGY trial
por: Weber, Michael A., et al.
Publicado: (2018)

A Mendelian Randomization Approach Using 3-HMG-Coenzyme-A Reductase Gene Variation to Evaluate the Association of Statin-Induced Low-Density Lipoprotein Cholesterol Lowering With Noncardiovascular Disease Phenotypes
por: Liu, Ge, et al.
Publicado: (2021)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
por: Alvi, Raza M., et al.
Publicado: (2018)

Cardiovascular Safety, Long‐Term Noncardiovascular Safety, and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta‐Analysis With Trial Sequential Analysis
por: Zhang, Xin‐Lin, et al.
Publicado: (2018)

Deep convolutional neural networks to predict cardiovascular risk from computed tomography
por: Zeleznik, Roman, et al.
Publicado: (2021)

Can deep learning classify stroke subtypes from chest X-rays?
por: Raghu, Vineet K., et al.
Publicado: (2021)

The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer
por: Zhang, Lili, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nj9b0gcspr2a179905t250drjn